Gordon Findlay, a Novo Nordisk executive, suddenly collapsed while standing behind President Donald Trump at a White House press event. The announcement focused on a new deal for weight-loss medications.
Findlay's knees buckled, causing him to nearly fall. Administration officials and pharmaceutical representatives quickly intervened to prevent him from hitting the floor.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
White House Press Secretary Karoline Leavitt confirmed that on-site medics attended to Findlay and that he was fine afterward.
According to press witnesses, Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, assisted Findlay by helping him to the ground to avoid head injury. Reporters were then asked to leave the Oval Office as cabinet members tended to him and elevated his legs.
This unexpected medical episode during a high-profile White House announcement was swiftly managed, allowing the event to continue with minimal disruption.